Robert W. Baird analyst Matthew Gillmor reiterated a Buy rating on Hms Holdings Corp (NASDAQ: HMSY) yesterday and set a price target of $30. The company’s shares closed yesterday at $28.90, close to its 52-week high of $30.
According to TipRanks.com, Gillmor is a 5-star analyst with an average return of 17.1% and a 69.8% success rate. Gillmor covers the Services sector, focusing on stocks such as Encompass Health Corporation, Addus Homecare Corp, and Envision Healthcare.
Hms Holdings Corp has an analyst consensus of Strong Buy, with a price target consensus of $28.67, implying a -0.8% downside from current levels. In a report released yesterday, Canaccord Genuity also maintained a Buy rating on the stock with a $33 price target.
.
See today’s analyst top recommended stocks >>
Based on Hms Holdings Corp’s latest earnings release for the quarter ending June 30, the company reported a quarterly GAAP net loss of $3.37 million. In comparison, last year the company had a net profit of $6.52 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HMS Holdings Corp. engages in the provision of cost containment solutions in the healthcare marketplace. The firm operates through its wholly owned subsidiaries, Health Management Systems, Inc. HealthDataInsights, Inc., HMS Care Analytics, Inc., IntegriGuard, LLC, and Reimbursement Services Group Inc..
